Pharma Industry Continues Building Open Innovation Models
The Nature Biotechnology website reports that seven large pharma companies and a biotech firm, Alnylam, have formed a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. This open innovation initiative lines up United Nations agency WIPO of Geneva with Washington, DC–based BIO Ventures for Global